Denmark Biotechnology & Medical Research

Ascendis Pharma A/S (ASND)

Track

Over the past 90 days, Ascendis Pharma A/S recorded nine insider transactions, resulting in a net negative value of approximately $4.36 million. While executives like Scott Thomas Smith and Jean Jacques Bienaime made small share purchases, significant selling activity by other officers, including Flemming Steen Jensen, drove the net outflow following the company's recent earnings report.
Ticker: ASND Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Ascendis Pharma A/S. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 2 Jun 2026
Value US$3,335,472.75 | Price 54.63 | Shares 46,097 (-2.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-02 2026-06-02 B Purchase
SMITH SCOTT THOMAS

EVP & Chief Financial Officer

Officer
46,097 -2.6%
54.63
US$3,335,473 		46,097 -2.6% 54.63 US$3,335,473
2026-06-01 2026-05-29 B Purchase
SMITH SCOTT THOMAS

EVP & Chief Financial Officer

Officer
22,823 +12.1%
274.21
US$3,670,388 		22,823 +12.1% 274.21 US$3,670,388
2026-06-01 2026-05-29 B Purchase
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
20,343 -39.7%
50.72
US$1,474,152 		20,343 -39.7% 50.72 US$1,474,152
2026-06-01 2026-05-29 B Purchase
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
200 +33.3%
222.30
US$44,460 		200 +33.3% 222.30 US$44,460
2026-06-01 2026-05-29 B Purchase
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
200 +50.0%
223.76
US$44,752 		200 +50.0% 223.76 US$44,752
2026-05-27 2026-05-26 B Purchase
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
200 +100.0%
239.37
US$47,874 		200 +100.0% 239.37 US$47,874
2026-05-27 2026-05-26 B Purchase
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
200 +inf%
236.24
US$47,247 		200 +inf% 236.24 US$47,247
2026-05-12 2026-05-11 S Sale
JENSEN FLEMMING STEEN

See Remarks

Officer
19,460 -100.0%
238.49
US$4,641,021 		19,460 -100.0% 238.49 US$4,641,021
2026-05-11 2026-05-11 PrS Proposed sale
JENSEN FLEMMING STEEN

Officer; EXECUTIVE VP HEAD OF PRODUCT SUPPLY AND QUALITY

Officer
19,460
238.49
US$4,641,022 		19,460 238.49 US$4,641,022
2026-03-09 2026-03-09 PrS Proposed sale
SINGEL STINA

Officer

Officer
3,782
240.00
US$907,680 		3,782 240.00 US$907,680
2026-03-06 2026-03-06 PrS Proposed sale
Bodenhoff Mads

Officer

Officer
10,000
237.53
US$2,375,308 		10,000 237.53 US$2,375,308
2026-03-06 2026-03-05 PrS Proposed sale
SMITH SCOTT THOMAS

Officer

Officer
10,000
240.00
US$2,400,000 		10,000 240.00 US$2,400,000
2026-03-05 2026-03-05 PrS Proposed sale
Shu Aimee

Officer

Officer
5,583
235.81
US$1,316,555 		5,583 235.81 US$1,316,555
2026-03-05 2026-03-05 PrS Proposed sale
SMITH SCOTT THOMAS

Officer

Officer
10,000
240.00
US$2,400,000 		10,000 240.00 US$2,400,000
2026-03-05 2026-03-05 PrS Proposed sale
Jan Moller Mikkelsen

CEO; Officer

Officer
94,000
241.38
US$22,689,720 		94,000 241.38 US$22,689,720
2026-03-04 2026-03-04 PrS Proposed sale
Morrison Lisa

Officer

Officer
10,105
236.34
US$2,388,195 		10,105 236.34 US$2,388,195
2026-03-04 2026-03-04 PrS Proposed sale
Shu Aimee

Officer; EXECUTIVE VICE PRESIDENT CHIEF MEDICAL OFFICER

Officer
7,290
239.22
US$1,743,914 		7,290 239.22 US$1,743,914
2026-03-02 2026-03-02 PrS Proposed sale
0.6
Fairey William

Director

Non-Executive Director
1,800
242.09
US$435,762 		1,800 242.09 US$435,762
2026-03-02 2026-03-02 PrS Proposed sale
IMANI SIHAM

Director

Non-Executive Director
1,800
242.09
US$435,762 		1,800 242.09 US$435,762
2026-03-02 2026-03-02 PrS Proposed sale
SMITH SCOTT THOMAS

Officer; EXECUTIVE VP CHIEF FINANCIAL OFFICER

Officer
18,349
242.09
US$4,442,109 		18,349 242.09 US$4,442,109
2026-03-02 2026-03-02 PrS Proposed sale
JENSEN MICHAEL WOLFF

Officer; EXECUTUVE VP CHIEF LEGAL OFFICER

Officer
18,349
242.09
US$4,442,109 		18,349 242.09 US$4,442,109
2026-03-02 2026-03-02 PrS Proposed sale
Bodenhoff Mads

Officer; SENIOR VP PRINCIPAL ACCOUNTING OFFICER

Officer
6,872
242.09
US$1,663,642 		6,872 242.09 US$1,663,642
2026-03-02 2026-03-02 PrS Proposed sale
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG

Officer; EXECUTIVE VP CHIEF ADMINISTRATIVE OFFICER

Officer
10,800
242.09
US$2,614,572 		10,800 242.09 US$2,614,572
2026-03-02 2026-03-02 PrS Proposed sale
Morrison Lisa

Director

Non-Executive Director
2,100
242.09
US$508,389 		2,100 242.09 US$508,389
2026-03-02 2026-03-02 PrS Proposed sale
HOLTUG LARS

Director

Non-Executive Director
2,100
242.09
US$508,389 		2,100 242.09 US$508,389
2026-03-02 2026-03-02 PrS Proposed sale
SPROGOE KENNETT

Officer; EXECUTIVE VP HEAD OF RESEARCH AND PROD DEVELOPMENT

Officer
10,800
242.09
US$2,614,572 		10,800 242.09 US$2,614,572
2026-03-02 2026-03-02 PrS Proposed sale
JENSEN FLEMMING STEEN

Officer; EXECUTIVE VP HEAD OF PRODUCT SUPPLY AND QUALITY

Officer
10,800
242.09
US$2,614,572 		10,800 242.09 US$2,614,572
2026-03-02 2026-03-02 PrS Proposed sale
1.8
Cha Albert

Director

Non-Executive Director
2,100
242.09
US$508,389 		2,100 242.09 US$508,389
2026-01-13 2026-01-13 PrS Proposed sale
MIKKELSEN JAN MOLLER

Officer; PRESIDENT CEO

Officer
86,860
211.99
US$18,413,631 		86,860 211.99 US$18,413,631
2025-12-04 2025-12-04 PrS Proposed sale
JENSEN MICHAEL WOLFF

Officer

Officer
10,000
208.10
US$2,081,019 		10,000 208.10 US$2,081,019
2025-12-02 2025-12-02 PrS Proposed sale
Jan Moller Mikkelsen

CEO; Officer

Officer
100,000
210.85
US$21,085,000 		100,000 210.85 US$21,085,000
2025-12-02 2025-12-02 PrS Proposed sale
SPROGOE KENNETT

Officer

Officer
10,000
209.32
US$2,093,222 		10,000 209.32 US$2,093,222
2025-12-02 2025-12-02 PrS Proposed sale
JENSEN FLEMMING STEEN

Officer

Officer
10,000
205.85
US$2,058,454 		10,000 205.85 US$2,058,454
2025-12-01 2025-12-01 PrS Proposed sale
SINGEL STINA

Officer

Officer
218
209.54
US$45,680 		218 209.54 US$45,680
2025-09-09 2025-09-09 PrS Proposed sale
JENSEN FLEMMING STEEN

Officer

Officer
5,000
203.70
US$1,018,503 		5,000 203.70 US$1,018,503
2025-08-29 2025-08-29 PrS Proposed sale
JENSEN MICHAEL WOLFF

Officer

Officer
5,000
193.00
US$965,000 		5,000 193.00 US$965,000
2025-08-27 2025-08-27 PrS Proposed sale
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG

Officer

Officer
3,036
193.94
US$588,814 		3,036 193.94 US$588,814
2025-08-20 2025-08-20 PrS Proposed sale
Jan Moller Mikkelsen

President and Chief Executive Officer

Officer
3,000
192.80
US$578,385 		3,000 192.80 US$578,385
2025-08-15 2025-08-15 PrS Proposed sale
JENSEN MICHAEL WOLFF

Officer

Officer
9,375
194.82
US$1,826,403 		9,375 194.82 US$1,826,403
2025-08-14 2025-08-14 PrS Proposed sale
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG

Officer

Officer
25,000
191.60
US$4,789,998 		25,000 191.60 US$4,789,998
2025-08-13 2025-08-13 PrS Proposed sale
Morrison Lisa

Director; Non-Executive Director

Non-Executive Director
2,158
191.07
US$412,319 		2,158 191.07 US$412,319
2025-08-13 2025-08-13 PrS Proposed sale
JENSEN FLEMMING STEEN

Officer

Officer
10,000
191.32
US$1,913,225 		10,000 191.32 US$1,913,225
2025-08-12 2025-08-12 PrS Proposed sale
SMITH SCOTT THOMAS

Officer

Officer
10,000
192.57
US$1,925,734 		10,000 192.57 US$1,925,734
2025-05-12 2025-05-12 PrS Proposed sale
Shu Aimee

Officer; EXECUTIVE VICE PRESIDENT CHIEF MEDICAL OFFICER

Officer
2,018
154.80
US$312,384 		2,018 154.80 US$312,384
2025-05-07 2025-05-07 PrS Proposed sale
JENSEN FLEMMING STEEN

Officer

Officer
10,938
162.20
US$1,774,164 		10,938 162.20 US$1,774,164
2025-05-07 2025-05-06 PrS Proposed sale
Shu Aimee

Officer; EXECUTIVE VICE PRESIDENT CHIEF MEDICAL OFFICER

Officer
4,204
166.61
US$700,412 		4,204 166.61 US$700,412
2025-05-06 2025-05-06 PrS Proposed sale
SPROGOE KENNETT

Officer

Officer
10,000
170.05
US$1,700,485 		10,000 170.05 US$1,700,485
2025-05-05 2025-05-05 PrS Proposed sale
JENSEN MICHAEL WOLFF

Officer

Officer
4,386
170.99
US$749,948 		4,386 170.99 US$749,948
2025-03-07 2025-03-07 PrS Proposed sale
JENSEN MICHAEL WOLFF

Officer

Officer
4,000
146.46
US$585,846 		4,000 146.46 US$585,846
2025-03-06 2025-03-06 PrS Proposed sale
JENSEN FLEMMING STEEN

Officer

Officer
10,000
152.39
US$1,523,933 		10,000 152.39 US$1,523,933
2025-03-06 2025-03-06 PrS Proposed sale
JENSEN MICHAEL WOLFF

Officer

Officer
1,614
152.25
US$245,735 		1,614 152.25 US$245,735
2025-03-05 2025-03-05 PrS Proposed sale
MIKKELSEN JAN MOLLER

Officer; PRESIDENT CHIEF EXECUTIVE OFFICER

Officer
7,789
155.13
US$1,208,292 		7,789 155.13 US$1,208,292
2025-03-05 2025-03-05 PrS Proposed sale
Bodenhoff Mads

Officer; SENIOR VP PRINCIPAL ACCOUNTING OFFICER

Officer
2,254
155.01
US$349,403 		2,254 155.01 US$349,403
2025-03-04 2025-03-04 PrS Proposed sale
Hartvig Camilla Harder

Officer; EXECUTIVE VP AND CHIEF COMMERCIAL OFFICER

Officer
2,222
152.12
US$338,021 		2,222 152.12 US$338,021
2025-03-04 2025-03-04 PrS Proposed sale
Bodenhoff Mads

Officer; SENIOR VP PRINCIPAL ACCOUNTING OFFICER

Officer
2,828
152.12
US$430,208 		2,828 152.12 US$430,208
2025-03-04 2025-03-04 PrS Proposed sale
0.6
Fairey William

Director

Non-Executive Director
1,006
152.12
US$153,037 		1,006 152.12 US$153,037
2025-03-04 2025-03-04 PrS Proposed sale
IMANI SIHAM

Director

Non-Executive Director
1,006
152.12
US$153,037 		1,006 152.12 US$153,037
2025-03-04 2025-03-04 PrS Proposed sale
Morrison Lisa

Director

Non-Executive Director
1,470
152.12
US$223,623 		1,470 152.12 US$223,623
2025-03-04 2025-03-04 PrS Proposed sale
HOLTUG LARS

Director

Non-Executive Director
1,470
152.12
US$223,623 		1,470 152.12 US$223,623
2025-03-04 2025-03-04 PrS Proposed sale
1.8
Cha Albert

Director

Non-Executive Director
1,470
152.12
US$223,623 		1,470 152.12 US$223,623
2025-03-04 2025-03-04 PrS Proposed sale
SINGEL STINA

Officer; EXECUTIVE VP HEAD OF CLINICAL DEV ONCOLOGY

Officer
13,344
152.12
US$2,029,949 		13,344 152.12 US$2,029,949
2025-03-04 2025-03-04 PrS Proposed sale
SMITH SCOTT THOMAS

Officer; EXECUTIVE VP CHIEF FINANCIAL OFFICER

Officer
13,344
152.12
US$2,029,949 		13,344 152.12 US$2,029,949
2025-03-04 2025-03-04 PrS Proposed sale
JENSEN MICHAEL WOLFF

Officer; EXECUTIVE VP CHIEF LEGAL OFFICER

Officer
13,344
152.12
US$2,029,949 		13,344 152.12 US$2,029,949
2025-03-04 2025-03-04 PrS Proposed sale
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG

Officer; EXECUTIVE VP CHIEF ADMINISTRATIVE OFFICER

Officer
7,719
152.12
US$1,174,249 		7,719 152.12 US$1,174,249
2025-03-04 2025-03-04 PrS Proposed sale
SPROGOE KENNETT

Officer; EXECUTIVE VP HEAD OF RESEARCH AND PRODUCT DEV

Officer
7,719
152.12
US$1,174,249 		7,719 152.12 US$1,174,249
2025-03-04 2025-03-04 PrS Proposed sale
JENSEN FLEMMING STEEN

Officer; EXECUTIVE VP HEAD OF PRODUCT SUPPLY AND QUALITY

Officer
7,719
152.12
US$1,174,249 		7,719 152.12 US$1,174,249
2025-03-03 2025-03-03 PrS Proposed sale
MIKKELSEN JAN MOLLER

Officer; PRESIDENT CHIEF EXECUTIVE OFFICER

Officer
7,800
155.14
US$1,210,089 		7,800 155.14 US$1,210,089
2025-02-21 2025-02-20 PrS Proposed sale
SINGEL STINA

Officer; EVP HEAD OF CLINICAL DEVELOPMENT CMO ONCOLOGY

Officer
2,729
155.20
US$423,542 		2,729 155.20 US$423,542
2025-02-20 2025-02-20 PrS Proposed sale
SMITH SCOTT THOMAS

Officer

Officer
10,000
154.27
US$1,542,671 		10,000 154.27 US$1,542,671
2025-02-19 2025-02-19 PrS Proposed sale
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG

Officer

Officer
39,375
152.70
US$6,012,750 		39,375 152.70 US$6,012,750
2025-02-19 2025-02-19 PrS Proposed sale
JENSEN MICHAEL WOLFF

Officer

Officer
5,000
151.32
US$756,607 		5,000 151.32 US$756,607
2025-02-18 2025-02-18 PrS Proposed sale
JENSEN FLEMMING STEEN

Officer

Officer
10,000
146.80
US$1,467,977 		10,000 146.80 US$1,467,977
2024-12-10 2024-12-10 PrS Proposed sale
SINGEL STINA

Officer; Executive Vice President, Head of Clinical Develop

Officer
2,119
129.13
US$273,621 		2,119 129.13 US$273,621
2024-12-10 2024-12-10 PrS Proposed sale
JENSEN MICHAEL WOLFF

Officer; Executive Vice President, Chief Legal Officer

Officer
2,119
129.13
US$273,621 		2,119 129.13 US$273,621
2024-12-10 2024-12-10 PrS Proposed sale
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG

Officer; EXECUTIVE VP CHIEF ADMINISTRATIVE OFFICER

Officer
1,222
129.13
US$157,794 		1,222 129.13 US$157,794
Explore more

More insider trading research around Ascendis Pharma A/S

More insider trades in Denmark
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe